Researchers develop early detection test for ovarian cancer

Researchers from Queen’s University Belfast have developed a test that may be able to detect ovarian cancer up to two years earlier than current approaches. Read more

New 'Trojan horse' cancer drug in development

The new drug can get inside tumour cells and has shown promise in patients with six different advanced, drug-resistant cancers. Read more

New AI test identifies women with ‘very high risk’ ovarian cancer

The test scans the shapes of tumour cells to pick out women with especially aggressive ovarian cancer, so treatment can be tailored to their needs. Read more

Immune cells cast DNA ‘webs’ that may help ovarian cancer spread

It is possible that preventing the webs from being formed could limit the spread and avoid the need for the omentum to be surgically removed Read more

Early research suggests weight loss drug could help treat advanced ovarian cancer

Weight loss drug Orlistat may help women with treatment-resistant ovarian cancer respond to chemotherapy again. Read more

Study suggests statin use may reduce risk of ovarian cancer

Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any type of ovarian cancer over the next decade than non-statin users. Read more

Lee Rowley MP leads Westminster Hall debate on the diagnosis and treatment of ovarian cancer

You can read the official record of the debate online. Read more

Olapirib maintenance therapy shows benefit for women with BRCA positive ovarian cancer

The results of the Phase III SOLO-1 trial have shown an increase in progression free survival for women with a BRCA mutation compared with a placebo. Read more

Research shows psychological support reduces fear of progression

Researchers assessed the effect of three 90-minute sessions of psychological support on depression, fear of progression and quality of life. Read more

Trial for the drug CT900 which targets ovarian cancer cells expanded into a larger trial

The drug could be suitable for women with ovarian cancer for whom chemotherapy has failed, and whose tumours have high levels of the alpha-folate receptor on the surface of cancer cells. Read more

New study suggests taking low dose aspirin may lower the risk of ovarian cancer

However there are risks associated with aspirin use and anyone considering using it should discuss with their doctor. Read more

Early trials of cancer vaccine include promising results for one woman with ovarian cancer

Among 11 evaluable cancer patients who had received more than the lowest dose of the vaccine, 6 had clinical benefit. Read more

New study investigates reasons behind varied responses to PARP inhibitors

A new study has been published, looking into why some patients respond to PARP inhibitors while others do not. Read more

New study suggests modern forms of the combined pill lower the risk of developing ovarian cancer

This supports previous findings for the risk-reducing effect of older forms of the combined pill. Read more

Northern Ireland Department of Health announces plans to improve access to new cancer drugs

The Department today announced plans to improve access to innovative new medicines for cancers and other conditions. Read more

Promising early research for a urine test which could diagnose ovarian cancer

A simple urine test could diagnose ovarian cancer at early stages. Read more

The ALDO Project - Avoiding Late Diagnosis in Ovarian Cancer

UCLH Cancer Collaborative is running a project focused on avoiding late diagnosis of ovarian cancer amongst BRCA carriers. Read more

Promising new treatment for ovarian and lung cancers

Early trials are showing promising results for a combined chemotherapy and targeted treatment regime. Read more

New iKnife could distinguish between cancer and healthy tissue

An intelligent surgical knife is being researched and developed, which could be able to tell the difference between ovarian cancer and healthy tissue. Read more

Niraparib (Zejula) accepted for use for advanced ovarian cancer by SMC

Niraparib (a PARP inhibitor) will be available as a maintenance treatment for women with relapsed ovarian cancer who do not have a BRCA mutation. Read more

Survey reveals one in four would not seek medical help over a symptom

A new survey has revealed that 1 in 4 people in the UK would not have a symptom examined for fear of what the doctor might find. Read more

Damages awarded to women with ovarian cancer over talcum powder use

Johnson & Johnson are to pay $4.7bn damages in talcum powder case. Read more

NHS to become the first health service in the world to routinely offer genetic testing

As the number of targeted treatments for ovarian cancer increases, it is vital that women who wish to have genetic testing are able to do so, in order to access appropriate and effective treatments. Read more